Education
About Us
Working with TipRanks
Follow Us
PRISM BioLab Co. LTD (JP:206A)
:206A
Total Valuation
PRISM BioLab Co. LTD has a market cap or net worth of ¥6.18B. The enterprise value is ¥5.57B.
Market Cap¥6.18B
Enterprise Value¥5.57B
Share Statistics
PRISM BioLab Co. LTD has 36,790,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,790,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PRISM BioLab Co. LTD’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -22.33%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-22.33%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee11.32M
Profits Per Employee-38.82M
Employee Count27
Asset Turnover0.07
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PRISM BioLab Co. LTD is ―. PRISM BioLab Co. LTD’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value3.66
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, PRISM BioLab Co. LTD had revenue of 305.62M and earned -1.05B in profits. Earnings per share was -33.53.
Revenue305.62M
Gross Profit160.54M
Operating Income-782.39M
Pretax Income-1.05B
Net Income-1.05B
EBITDA-1.05B
Earnings Per Share (EPS)-33.53
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
PRISM BioLab Co. LTD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change-58.42%
50-Day Moving Average182.00
200-Day Moving Average244.90
Relative Strength Index (RSI)42.62
Average Volume (3m)239.10K
Important Dates
PRISM BioLab Co. LTD upcoming earnings date is Nov 13, 2025, TBA (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 13, 2025
Ex-Dividend Date―
Financial Position
PRISM BioLab Co. LTD as a current ratio of 4.40, with Debt / Equity ratio of ―
Current Ratio4.40
Quick Ratio4.40
Debt to Market Cap0.00
Net Debt to EBITDA4.19
Interest Coverage Ratio-57.97
Taxes
In the past 12 months, PRISM BioLab Co. LTD has paid 1.31M in taxes.
Income Tax1.31M
Effective Tax Rate>-0.01
Enterprise Valuation
PRISM BioLab Co. LTD EV to EBITDA ratio is -8.05, with an EV/FCF ratio of -137.16.
EV to Sales27.62
EV to EBITDA-8.05
EV to Free Cash Flow-137.16
EV to Operating Cash Flow56.23
Balance Sheet
PRISM BioLab Co. LTD has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share¥111.90
Margins
Gross margin is ―, with operating margin of -256.00%, and net profit margin of -343.40%.
Gross Margin―
Operating Margin-256.00%
Pretax Margin-342.98%
Net Profit Margin-343.40%
EBITDA Margin-342.98%
EBIT Margin-342.98%
Analyst Forecast
The average price target for PRISM BioLab Co. LTD is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―